|
⚲
|
| TENX Biopharma Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001485860 |
| Sale | 2010-02-03 ($6.0 M Offered, $5.5 M Sold) |
| Fund | |
| Phone | 3049821240 |
| Address | 109 North Orianna Street Philadelphia, 19106 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Gardiner Smith | |
| Robert Harow | |
| Chia Sun | |
| Nathan Asher |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Arachne (SAC) Holdings Ltd.
✚
|
0.0 | |
|
MHM Real Estate LLC
✚
|
0.0 | |
|
Aramas Capital Management LLC
✚
|
0.0 | |
|
Aravive, Inc.
✚
|
0.0 | |
|
Amadeus Medical Holdings, Inc.
✚
|
0.0 | |
|
ARB Berhad
✚
|
0.0 | |
|
ARB Flagship Multi-Strategy Series
✚
|
0.0 | |
|
Bnk To The Future Amon US SP, a Segregated Portfolio of Bnk
✚
|
0.0 | |
|
Bnk To The Future Aqua Digital US SP, a Segregated Portfolio
✚
|
0.0 | |
|
AR-1211 Fund I, a series of MV Funds, LP
✚
|
0.0 |